Observational studyFrontiers in endocrinology2022
Association of Sarcopenia and A Body Shape Index With Overall and Cause-Specific Mortality.
Observational study in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- Incidence, mortality, and survival trends of retinoblastoma in children: a systematic review and meta-analysis of population-based studies.Italian journal of pediatrics · 2026Pooled it
- A systematic review and meta-analysis of the association between sarcopenia and myocardial infarction.BMC geriatrics · 2023Pooled it
- Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis.Frontiers in oncology · 2023Pooled it
- Triglyceride-related metabolic indices and low relative muscle mass: a cross-sectional analysis of SMILE and NHANES.Endocrine · 2026Article
- Postoperative sarcopenia in older patients with hip fractures: incidence and associated risk factors in a retrospective cohort study.Frontiers in medicine · 2026Article
- Midlife BMI and A Body Shape Index in relation to mortality and coronary heart disease events in a nationwide cohort.Frontiers in nutrition · 2026Article
- A body shape index and sarcopenia risk in middle-aged and older adults: evidence from the China Health and Retirement Longitudinal Study.European journal of medical research · 2025Article
- Article
- Determination of cardiometabolic risk in pre- and post-menopausal women.BMC cardiovascular disorders · 2025Article
- Relationship Between A Body Shape Index and Self-Reported Stress Urinary Incontinence Among US Women: A Cross-Sectional Analysis.International urogynecology journal · 2025Article
- Association of weight-adjusted waist index with all-cause and cardiovascular mortality in individuals with osteoarthritis.BMC musculoskeletal disorders · 2025Article
- Joint association of systemic inflammatory response index and sarcopenia with mortality among individuals with self-reported cancer.BMC cancer · 2025Article
- The usefulness of a body shape index in assessing muscle function and strength in older adults hemodialysis patients.Frontiers in endocrinology · 2025Article
- Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity.Scientific reports · 2024Article
- The Abdominal Adiposity Index (A Body Shape Index) Predicts 10-Year All-Cause Mortality in Elderly Active Non-Obese Subjects.Journal of clinical medicine · 2024Article
- Association between a body shape index and female infertility: a cross-sectional study.BMC women's health · 2024Article
- The predictive ability of ABSI compared to BMI for mortality and frailty among older adults.Frontiers in nutrition · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This observational study aimed to examine the association between the A Body Shape Index (ABSI) and/or sarcopenia and total, cardiovascular, and cancer mortality. Methods: The associations of sarcopenia and ABSI with all-cause, cardiovascular, and cancer mortality were assessed in 4,488 participants from the 1999-2004 National Health and Nutrition Examination Survey (NHANES) who were followed up until December 31, 2015. Models were analyzed separately for men and women and adjusted for age, race, and other confounding factors. ABSI was assessed as a continuous measurement by quartile for men and women. Population attributable fractions (PAFs) were calculated to assess mortality caused by sarcopenia and/or ABSI in the study population. Results: When ABSI was assessed as a continuous variable, the ABSI quartile showed a linear trend for total ( Conclusion: The ABSI value was significantly associated with all-cause and cardiovascular mortality, and the co-existence of higher ABSI values and sarcopenia can contribute to a more significant death risk in comparison with high ABSI values or sarcopenia. Moreover, the ABSI values in combination with the ASMI can be used to preliminarily evaluate the content and distribution of fat and muscle and to predict the risk of death in obese and sarcopenic populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.